Skip to main content
Caplight Logo









Freedom Biosciences

Freedom Biosciences

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.freedombio.co/

Last Round

Seed

Aug 23, 2022

Total Funding Raised

$10.5M

Company Overview

Freedom Biosciences is a clinical-stage biotechnology company that develops next-generation neuropsychiatric therapeutics, including ketamine-based and psychedelic-inspired treatments for mental health conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Mental Health, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyneuropsychiatric therapeuticsketamine therapypsychedelic medicinedrug discoveryclinical trialstreatment-resistant depressionmental healthsubstance use disordersbiopharmapsychedelicsclinical-stage biotechpharmaceutical developmentmental health tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Freedom Biosciences Comparables

Compare Freedom Biosciences with similar companies based on industry and business-model similarity.

Freedom Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gilgamesh Pharmaceuticals
86%
Reunion Neuroscience Inc.
81%
Delix Therapeutics
79%

Freedom Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 23, 2022

Key People

Founding team and executive leadership

Dina Burkitbayeva

CEO Co-founder

Founding Team

Freedom Biosciences Investors

Notable investors and investment history

Freedom Biosciences investors
InvestorRounds
LongeVCSeed
Village GlobalSeed
Village GlobalSeed
FundRxSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2026

    Monthly visitors grew 219% MoM, reaching 4.4K.

Freedom Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Freedom Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Freedom Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range10
Year Founded2021
Last FundingAug 23, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?